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Background: Eosinophils recognize various stimuli, such as cytokines, chemokines, immunoglobulins,
complement, and external pathogens, resulting in their accumulation in mucosal tissues and the pro-
gression of inﬂammation. Eosinophils are also involved in innate Th2-type immune responses mediated
through endogenous danger signals, including IL-33, uric acid (UA), or ATP, in non-sensitized mice
exposed to environmental allergens. However, the mechanism involved in eosinophil responses to these
danger signals remains insufﬁciently understood.
Methods: We examined migration, adhesion, superoxide production and degranulation of human eo-
sinophils. Isolated eosinophils were incubated with monosodium urate (MSU) crystals and ATPgS, a non-
hydrolysable ATP analogue. To determine the involvement of P2 or P2Y2 receptors in eosinophil re-
sponses to UA and ATP, eosinophils were preincubated with a pan-P2 receptor inhibitor, oxidized ATP
(oATP), or anti-P2Y2 antibody before incubation with MSU crystals or ATPgS.
Results: MSU crystals induced adhesion of eosinophils to recombinant human (rh)-ICAM-1 and induced
production of superoxide. oATP abolished eosinophil responses to MSU crystals, suggesting involvement
of endogenous ATP and its receptors. Furthermore, exogenous ATP, as ATPgS, induced migration of eo-
sinophils through a model basement membrane, adhesion to rh-ICAM-1, superoxide generation, and
degranulation of eosinophil-derived neurotoxin (EDN). oATP and anti-P2Y2 signiﬁcantly reduced these
eosinophil responses.
Conclusions: ATP serves as an essential mediator of functional responses in human eosinophils. Eosin-
ophil responses to ATP may be implicated in airway inﬂammation in patients with asthma.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Eosinophils are known as effector cells involved in host pro-
tection against parasite infections and in pathological processes
involved in allergic diseases.1,2 In response to various stimuli, eo-
sinophils release toxic granule proteins and producent of Respiratory Medicine,
, Japan.
a).
ety of Allergology.
rgology. Production and hosting by Elseproinﬂammatory mediators (cytokines and chemokines), which
may cause tissue damage, dysfunction,3 and remodeling.4,5 Eosin-
ophils accumulate in inﬂamed tissue in response to Th2 cytokine
derived group 2 innate lymphoid cells and conventional Th2-type
CD4þ T cells, and may serve as a pivotal player in asthma.
Recently, eosinophils have been shown to recognize a wide va-
riety of pathogens and environmental allergens through engage-
ment of receptors for pathogen-associated molecular patterns.
Likewise, damage-associated molecular patterns (DAMPs), or
danger signals, are also involved in eosinophil activation. DAMPs are
endogenous factors that are usually stored within cells and can be
released into extracellular spaces under conditions of cellular stressvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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that can be released quickly fromhumanbronchial epithelial cells in
response to several environmental allergens and initiate allergic
airway inﬂammation.7 Other prototypical DAMPs include ATP, Kþ
ions, uric acid (UA), HMGB-1, and S100 calcium-binding protein
family members.8e10 Recent studies show that DAMPs might either
directly or indirectly mediate pathophysiological processes in
asthma and allergic disorders.7,11e14 UA serves as a potent Th2 cell
adjuvant, when administered into airways with an innocuous OVA
antigen, by recruiting DCs.11 Upon exposure to inhaled allergens, UA
can be released into the airways and lungs of mice.13,14 In addition,
administration of UA into the airways of naive animals induces
extracellular release of IL-33, leading to both innate and adaptive
type 2 immune responses.13 Although these ﬁndings suggest that
UA might be implicated in the induction of allergic airway inﬂam-
mation, our knowledge of the immunologic mechanism underlying
the effects of UA on type 2 immune responses is limited. Indeed, UA
induced cytokine production in human eosinophils,15 suggesting
that UA is involved in the initiation of eosinophilic inﬂammation.
Similar to UA, ATP is also recognized as a DAMP that is implicated
in Th2-type innate and adaptive immune responses. Inhaled aero-
allergens elicit secretion of ATP in the lungs of naive or OVA-
sensitized mice.7,14 ATP also mediates release of IL-33, IL-5, and IL-
13 in the lungs of naive mice exposed to aeroallergens and induces
pathophysiologic features of asthma.14 Likewise, ATP is involved in
the release of IL-33 from airway epithelial cells in response to envi-
ronmental fungus and the recruitment of DCs.7,14 In addition, ATP
mediates recruitment of eosinophils to lung in OVA-sensitizedmice,
suggesting that ATP promotes a wide variety of eosinophilic re-
sponses. Several studies showed that P2-type purinergic receptors
are involved in triggering diverse eosinophil functions.16 Nonethe-
less, the effect of ATP on eosinophils remains poorly understood.
In this study, to clarify the mechanism of cellular accumulation
and effector functions of human eosinophils in response to danger
signals, we examined the response of eosinophils to monosodium
urate (MSU) crystals and ATP. We found that MSU crystals induced
chemotaxis and adhesion of eosinophils. Pharmacological agents, a
broad P2 receptor antagonist, inhibited eosinophil chemotaxis in
response to MSU crystals, suggesting the involvement of ATP
endogenous to eosinophils.We also found exogenous ATP promoted
diverse eosinophil function, including adhesion to rh-ICAM-1, trans-
basement membrane migration (TBM), production of superoxide,
and degranulation. Inhibition of P2 receptors by a pharmacological
agent or anti-P2Y2 reduced eosinophil responses to ATP. These
ﬁndings suggest that eosinophils recognize extracellular danger
signals and produce effector functions. Endogenous and exogenous
ATP may play a pivotal role in mediating such eosinophil responses.
Methods
Reagents
Percoll was obtained from Pharmacia (Uppsala, Sweden). Anti-
CD16 antibody-coated magnetic beads were purchased from Mil-
tenyl Biotec (Auburn, CA, USA). Hanks' balanced salt solution
(HBSS), PBS and fetal calf serum (FCS) were obtained from Life
Technologies (Grand Island, NY, USA). Recombinant human IL-5
was obtained from GeneTex (Irvine, CA, USA). RPMI 1640 medium
was from Life Technologies. Monosodium urate (MSU) crystals, ATP
periodate oxidized sodium salt (oATP), ATP-50 g-[thio]tetralithium
salt (ATPgS) were from SigmaeAldrich (St. Louis, MO, USA). The
MSU crystals were suspended in the 5% GEL/HBSS at 10 mg/ml and
diluted serially. Rabbit polyclonal anti-P2Y2 Ab was from Thermo
Fisher Scientiﬁc (Santa Cruz, CA, USA). Control rabbit IgG was from
Santa Cruz Biotechnology (Santa Cruz, CA, USA).Eosinophil isolation
Human eosinophils were isolated from the peripheral blood of
60 healthy volunteers. They did not have history of allergic diseases
or have mild hay fever with a peripheral blood differential eosin-
ophil count of <5%. The numbers of males and females were
comparable. They ranged in age from 20 to 50 years. Human eo-
sinophils were isolated by negative selection with anti-CD16
microbeads as previously described, with minor modiﬁcations.17
This protocol consistently yielded >99% eosinophil purity (mean,
99.2%) as determined according to morphologic criteria using May-
Grünwald-Giemsa staining. Eosinophil viability was >99%, as
determined by Trypan blue dye exclusion. Eosinophils were
resuspended in HBSS supplemented with gelatin to a ﬁnal con-
centration of 0.1% (HBSS/gel). The responses of eosinophils from
normal individuals and from patients with mild hay fever were
quantitatively equivalent; therefore, the data were pooled. The
Saitama Medical University Institutional Review Board approved
the protocol to obtain blood from volunteers, all of who provided
informed consent.
Eosinophil adhesion assay
Eosinophil adhesion to rh-ICAM-1-coated plates was examined
by measuring the residual eosinophil peroxidase (EPO) activity of
adherent eosinophils, as previously described.18e22 Eosinophils
(100 ml of 1 105 cells/ml in HBSS/gel) were incubated at 37 C for
20 min in rh-ICAM-1-coated plates in the presence or absence of
the MSU crystal suspensions (0.01e1 mg/ml) or ATPgS
(1e100 mM). Eosinophils were pre-incubated with oATP (30 mM)
at 4 C for 15 min before to the assay in selected experiments.
After washing the plate with HBSS 5 times, 100 ml of HBSS/gel was
then put into the wells. Standards comprised of 100 ml of serially
diluted cell suspensions (1  103, 3  103, 1  104, 3  104, and
1 105 cells/ml) were put into empty wells. Subsequently, the EPO
substrate (1 mM o-phenylenediamine, 1 mM H2O2, and 0.1% Triton
X-100 in Tris buffer, pH 8.0) was added to all wells and the plates
were incubated for 30 min at room temperature. The reaction was
stopped by adding 50 ml of 4 M H2SO4 and absorbance was
measured at 490 nm. Each experiment was performed in
quadruplicate through use of eosinophils from a single volunteer.
The percentage of eosinophil adhesion was calculated from log
dose response curves and mean values were used. Eosinophil
viability after incubation was greater than 98%, as determined by
Trypan blue dye exclusion.
Eosinophil trans-basement membrane migration
The TBM of eosinophils was examined using a modiﬁed Boy-
den's chamber method.15,23 A Matrigel®-coated Transwell® insert
(pore size 3 mm, Becton Dickinson Labware) was used as the upper
chamber, and an ordinary tissue-culture plate well was used as the
lower chamber. Eosinophils were suspended in HBSS/gel at 1 106
cells/ml. One hundred microliters of the eosinophil suspension
were put into the upper chamber and serial dilutions of ATPgS
suspension were placed onto the lower chamber. Eotaxin (100 ng/
ml) was used as a positive control. Alternatively, eosinophils sus-
pended with 100 mM ATPgS were put into the upper chamber, and
100 mM ATPgS were placed onto the lower chamber in a checker-
board fashion. Eosinophils were pre-incubated with oATP (30 mM)
at 4 C for 15 min before assay in selected experiments. After 2 h of
incubation at 37 C and 5% CO2, the cells that migrated to the lower
chamber were collected and counted using light microscopy. The
studywas conducted in duplicate and results were presented as the
percentage of the initial total number of cells that migrated.
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Eosinophil superoxide generation was measured in 96-well
plates (Becton Dickinson Labware, NY, USA) using a method
based on the superoxide dismutase (SOD)-inhibitable reduction of
cytochrome C, as previously described.18e20,22 We initially added
SOD (0.2 mg/ml in HBSS/gel; 20 ml) to SOD control wells and then
HBSS/gel to all wells to obtain the ﬁnal volume (100 ml). The
eosinophil density was adjusted to 1.25  106 cells/ml of HBSS/gel
mixed 4:1 with cytochrome C (12 mg/ml of HBSS/gel), and 100 ml of
eosinophil suspension was then placed onto all wells. Immediately
after adding MSU crystal suspensions (0.01e1 mg/ml) or ATPgS
(1e100 mM), the absorbance of the cell suspensions in thewells was
measured at 550 nm in an Immuno-Mini (NJ-2300; Japan Intermed,
Tokyo, Japan). Subsequently, themeasurements were repeated over
the next 240min. To determine inhibition of O2 generation induced
by ATP, eosinophils were pre-incubated with oATP (30 mM) at 4 C
for 15 min in selected experiments. The plates were incubated in a
5% CO2 incubator at 37 C between measurements. Each reaction
was performed in duplicate against the control reaction in wells
containing 20 mg/ml of SOD. The results were adjusted for a 1 ml
reaction volume, and O2 generationwas calculated at an extinction
coefﬁcient of 21.1 mM1 cm1, as nanomoles of cytochrome C
attenuated per 1.0 106 cells/mlminus the SOD control.18,24,25 Each
value during the incubation period was examined to evaluate the
effects of MSU crystal or ATPgS on eosinophil O2 generation. Cell
viability, examined by Trypan blue exclusion at the end of each
experiment, remained at 95% after the 240-min incubation period
with the activator.
Eosinophil degranulation assay
Eosinophil degranulation was analyzed by quantiﬁcation of
eosinophil-derived neurotoxin (EDN) release into cell-free super-
natants.15,26 Brieﬂy, freshly isolated eosinophils were suspended in
HBSS with 25 mM HEPES and 0.01% gelatin (240 min culture) at
1  106 cells/ml. Cells were placed onto the wells of 96-well tissue
culture plates. To examine the role of the P2Y2 nucleotide receptor
in eosinophil EDN degranulation in response to ATPgS, eosinophils
were pre-incubated with 30 mM rabbit polyclonal anti-P2Y2 Ab or
control rabbit IgG for 15 min before the addition of ATPgS. After
incubation, cell-free supernatants were collected and stored
at 20 C until EDN was measured by ELISA. The EDN ELISA was
performed using ELISA kits (Medical and Biological Laboratory,
Nagoya, Japan) as previously described.27 The lowest detection
limit of the standard curve was 0.6 ng/ml for this assay. All assays
were conducted in duplicate.
Statistical analysis
Results were expressed asmean ± SEM. Statistical analyses were
performed using one-way ANOVA (TukeyeKramer multiple com-
parisons test), and differences between pairs of groups were
analyzed with the paired Student t test. Values of P < 0.05 were
considered statistically signiﬁcant.
Results
Endogenous ATP is involved in eosinophil adhesion and superoxide
generation stimulated by MSU crystals
Because UA may be abundant in inﬂamed tissues,6,13,28 we
examined whether MSU crystals induce eosinophil adhesion to rh-
ICAM-1 in a model endothelium, and whether MSU crystals pro-
mote superoxide generation by eosinophils. IL-5 is a potentactivator of human eosinophils29 and was used as a control. MSU
crystals induced adhesion of eosinophils to rh-ICAM-1 in a
concentration-dependent manner (Fig. 1A). When eosinophils
were stimulated with 0.1 and 1 mg/ml MSU crystals, the increase in
eosinophil adhesionwas signiﬁcant, as compared with the medium
control (4.8 ± 0.4% bymediumversus 14.8 ± 1.9% by 0.1 mg/ml MSU
crystals, and 20.8 ± 1.6% by 1 mg/ml MSU crystals, P < 0.01, N ¼ 5).
Maximum eosinophil adhesion reached about 70% of the IL-5-
induced eosinophil adhesion, suggesting that MSU crystals are a
potent initiator of eosinophil adhesion. In addition, MSU crystals at
>0.1 mg/ml signiﬁcantly induced superoxide production by eosin-
ophils as compared with the medium control (0.1 ± 0.03 nmol by
medium versus 0.3 ± 0.1 nmol by 0.1 mg/ml MSU crystals, P < 0.01;
N ¼ 6, at 240 min) (Fig. 1C). Additionally, at higher concentrations
(e.g., 1 mg/ml), MSU crystals induced rapid induction of superoxide
production (0.3 ± 0.04 nmol at 20 min, 0.6 ± 0.08 nmol at 40 min,
0.7 ± 0.08 nmol at 60 min, 0.07 ± 0.09 nmol at 90 min, and
0.7 ± 0.09 nmol at 120 min, P < 0.01, N ¼ 6), which plateaued at
120 min.
We previously reported that autocrine ATP is involved in MSU
crystals-induced cytokine production by human eosinophils.15
Hence, we hypothesized that ATP may be involved in MSU
crystals-induced eosinophil adhesion and superoxide generation.
To test this hypothesis, we examined the effects of oATP, a broad
pharmacological inhibitor of P2 receptors. oATP signiﬁcantly
reduced eosinophil adhesion to rh-ICAM-1 in response to MSU
crystals (19.6 ± 1.6% by 0.1 mg/ml MSU crystals with medium
versus 10.6 ± 1.1% with oATP, P < 0.01; 26.2 ± 1.4% by 1 mg/ml MSU
crystals with medium versus 13.3 ± 1.1% with oATP, P < 0.01, N ¼ 5)
(Fig. 1B). oATP also signiﬁcantly attenuated superoxide production
by eosinophils stimulated with 1 mg/ml MSU crystals
(0.9 ± 0.09 nmol with medium versus 0.4 ± 0.07 nmol with oATP,
P < 0.01, N ¼ 6, at 240 min) (Fig. 1D). Up to an approx. 50e60%
reduction in eosinophil adhesion and superoxide production was
observed with optimal concentrations of oATP.
Exogenous ATP induces adhesion of eosinophils to rh-ICAM-1 and
trans-basement membrane migration by engaging P2 purinergic
receptors
Involvement of endogenous ATP in eosinophil adhesion and
effector function induced by MSU crystals led us to examine the
effect of exogenous ATP on eosinophil function. We previously
found that exogenous ATP exerts chemoattractant activity for hu-
man eosinophils.15 In addition, autocrine ATP promoted neutrophil
chemotaxis through P2Y2 and A3 receptors.29 Therefore, we hy-
pothesized that exogenous ATP can induce eosinophil inﬁltration to
tissues and that P2 receptors are involved in this process.
Thus, we incubated eosinophils with non-hydrolysable ATP,
ATPgS, and examined eosinophil adhesion to rh-ICAM-1-coated
plates. ATPgS modestly, but signiﬁcantly, induced eosinophil
adhesion to rh-ICAM-1 (adhesion of eosinophils: 7.9 ± 0.4% by
medium versus 17.6 ± 1.8% by ATPgS (P < 0.01) and 36.3 ± 4.1% by
IL-5 (P < 0.01), N ¼ 5) (Fig. 2A). The magnitude of eosinophil
adhesion induced by ATPgSwas approximately 50% that induced by
IL-5. To examine the involvement of P2 receptors, we pre-incubated
eosinophils with oATP. oATP reduced eosinophil adhesion to the
near baseline level (eosinophil adhesion: 17.9 ± 1.4% by ATPgS
versus 9.2 ± 0.6% by ATPgS with oATP (P < 0.01), N ¼ 5). Thus,
exogenous ATP can induce eosinophil adhesion through P2 re-
ceptors (Fig. 2B).
To examine whether ATP induces migration of eosinophils, we
employed a basement membrane model. The effects of ATP were
analyzed in a checkerboard system by placing eosinophils, with or
without ATPgS (100 mM), in the upper chamber and placing
Fig. 1. Effects of MSU crystals on eosinophil adhesion to rh-ICAM-1 (A, B), production of superoxide anion (C, D) and modiﬁcation of these function by P2 receptor pharmacological
antagonist (B, D). (A) Eosinophils were incubated with or without MSU crystals suspensions (0.01e1 mg/ml) at 37 C for 20 min in rh-ICAM-1 coated plates. After washing the plates,
the EPO substrate and 100 ml of HBSS/FCS were added to all wells, followed by incubation for 30 min at room temperature. The reaction was stopped by 4 M H2SO4 (50 ml) and
absorbance at 490 nm was determined. The percentage of eosinophil adhesion was determined from mean values calculated from log dose response curves. IL-5 was used as a
positive control. (B) Eosinophils were pre-incubated with or without 30 mM oATP at 4 C for 15 min and subsequently incubated with or without serial dilution of an MSU crystal
suspension under the same condition. The residual EPO activity of adherent eosinophils was measured as in A. (C) A 4:1 mixture of eosinophil suspension and cytochrome C was
incubated with or without various concentrations of MSU crystal suspension at 37 C for up to 240 min. O2 generation was evaluated by measuring absorbance of the cell sus-
pensions at 550 nm every 30 min for up to 240 min, and was calculated at an extinction coefﬁcient of 21.1 mM1 cm1 as nanomoles of cytochrome C reduced per 1.0  106 cells/ml
minus the SOD control. (D) Eosinophils were pre-incubated with oATP (30 mM) or medium at 4 C for 15 min before assay and then were incubated with or without 1 mg/ml. MSU
crystal suspension under the same condition. O2 generation at 240 min was measured as in (C). Results show the mean ± SEM from 5 different eosinophil preparations in (A) and
(B), and 6 in (C) and (D). *p < 0.01, **p < 0.05, compared with medium alone. MSU, monosodium urate; EPO, eosinophil peroxidase; oATP, ATP periodate oxidized sodium salt.
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ATPgS in the lower chamber alone promoted signiﬁcant trans-
basement membrane migration of eosinophils whereas ATPgS in
the upper chamber alone did not (1.4 ± 0.7% by medium versus
11.8 ± 1.3% by ATPgS in lower chamber, P < 0.05) (Fig. 3A). The
magnitude of ATPgS-induced migration was approximately 60% of
eotaxin (20.1 ± 5.0% by eotaxin in lower chamber, P < 0.01, N ¼ 5)
(Fig. 3A). Furthermore, when ATPgS was added to the upper
chamber (i.e., ATPgS in both upper and lower chambers), the
migration of eosinophils was suppressed, suggesting that ATPgS
serves as a chemotactic factor for eosinophils.
To investigate the role of P2 purinergic receptors, eosinophils
were preincubated with or without oATP before being placed in the
upper chamber. oATP signiﬁcantly inhibited ATPgS-mediated
eosinophil migration (11.8 ± 1.3% by medium versus 2.8 ± 0.7% by
oATP, P < 0.05, N ¼ 5) (Fig. 3B). Thus, ATP likely induces trans-
basement membrane migration of human eosinophils through P2
receptors.
ATP induces superoxide production and EDN degranulation of
eosinophils by engaging P2 receptors
Previous study showed that ATP induces eosinophil cytokine
production through P2Y2 receptors.15,30 To examine whether
exogenous ATP promotes eosinophil effector function, we incu-
bated eosinophils with ATPgS and analyzed superoxide produc-
tion. ATPgS signiﬁcantly induced superoxide generation
(0.1 ± 0.04% by medium at 240 min versus 0.3 ± 0.03 nmol by
100 mM ATPgS at 240 min, P < 0.01, N ¼ 6) (Fig. 4A). In addition,the eosinophil granule protein, EDN, was detectable in cell-free
supernatants (33 ± 12.8 ng/ml by medium versus
181.1 ± 24.7 ng/ml by ATPgS, P < 0.01, N ¼ 5), suggesting that
ATPgS also induces eosinophil degranulation. oATP completely
inhibited eosinophil superoxide generation in response to ATPgS
at 240 min (0.34 ± 0.03 nmol with ATPgS versus 0.07 ± 0.03 nmol
with oATP, P < 0.05, N ¼ 6) (Fig. 4B).
Although inhibition of eosinophil responses by a broad-range P2
receptor inhibitor suggested the involvement of P2 receptors, the
role of speciﬁc P2 receptor(s) remained unclear. The P2Y2 receptor
appears to be a possible candidate, since it is consistently expressed
in eosinophils, and eosinophil cytokine production is dependent on
receptor expression.15,31 To examine the role of P2Y2 receptors in
eosinophil degranulation, an anti-P2Y2 receptor antibody was
employed. The anti-P2Y2 receptor antibody completely inhibited
EDN release by eosinophils (157 ± 8.4 ng/ml by murine IgG1 anti-
body versus 18.9 ± 10.6 ng/ml by anti-P2Y2 antibody, P < 0.01,
N ¼ 5) (Fig. 5). Thus, the P2Y2 receptor is likely involved in eosin-
ophil degranulation in response to exogenous ATP.
Discussion
In this study, we found that two major DAMPs are involved in
the induction of eosinophil function. MSU crystal induced eosino-
phil adhesion and promoted the release of inﬂammatory media-
tors. Exogenous ATP also promoted TBM migration of eosinophils
and promoted the production of inﬂammatory mediators. These
processes are likely driven through P2 receptors, in particular P2Y2
receptors. Importantly, eosinophil responses to UA were abolished
Fig. 2. Effects of ATPgS on eosinophil adhesion to rh-ICAM-1 by engagement of P2
receptors. (A) Eosinophils were incubated with or without various concentrations of an
ATPgS at 37 C for 20 min in rh-ICAM-1 coated plates. The adhesion rate of eosinophils
was measured as described in Fig. 1. IL-5 was used as a positive control. (B) Eosinophils
were pre-incubated with or without 30 mM oATP at 4 C for 15 min and then were
incubated with or without 100 mM ATPgS under the same condition. Results show the
mean ± SEM from 5 different eosinophil preparations. *p < 0.01, compared with me-
dium alone.
Fig. 3. Effects of ATPgS on eosinophil trans-basement membrane migration by
engagement of P2 receptors. (A) Eosinophil suspensions with or without 100 mM
ATPgS were added to the upper chamber, and 100 mM ATPgS was added to the lower
chamber in a checkerboard fashion. Eotaxin (100 ng/ml) in the lower chamber was
used as a positive control. After 2 h at 37 C, the cells that migrated to the lower
chambers were collected and counted using light microscopy. The data show the
percentage of migrated cells to the total number of initial cells. Results show the
mean ± SEM from ﬁve different eosinophil preparations. p < 0.01, compared with
medium alone in the lower chamber. (B) Eosinophils were pre-incubated with or
without 30 mM oATP at 4 C for 15 min. Subsequently, eosinophil suspensions were
added to the upper chamber and 100 mM ATPgS was added to the lower chamber. The
migration ratio was determined as described in (A). Results show the mean ± SEM
from ﬁve different eosinophil preparations. p < 0.01, compared with medium alone in
the lower chamber.
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eosinophil ATP is involved in eosinophil responses to UA. These
ﬁndings suggest that exogenous and endogenous danger signals
coordinately drive the inﬂammatory process attributed to activated
eosinophils. These observations may partially explain why eosin-
ophilic inﬂammation is prolonged in certain patients with asthma
once the process is initiated.
Earlier, UA or MSU crystals were shown to initiate Th1- or Th17-
type immune responses, including activation of neutrophil func-
tions,32 inﬂammation by neutrophil extracellular traps in gout,33 IL-
1b release from macrophages, and mediating adjuvant activities
associated with infection and cell death.27 We previously found
that eosinophils respond to MSU crystal, resulting in chemotaxis,
pro-inﬂammatory cytokine production and degranulation.15 In this
study, we add to this knowledge by proposing that other important
eosinophil functions were induced by MSU crystal, such as adhe-
sion and superoxide production. UA may therefore induce eosino-
phil accumulation at the site of inﬂammation and accelerate tissue
damage by promoting the production of proinﬂammatory factors
by eosinophils. In fact, UA was shown to drive Th2-type immune
responses in the lungs.12,13 UA was involved in allergic bronchial
inﬂammation induced by airway exposure to house dust mite
(HDM) allergens. In addition, UA was also involved in protease-
induced Th2-type airway immune responses by triggering IL-33
secretion by bronchial epithelial cells in naive mice. Conse-
quently, UA may contribute not only to the progression of Th2-type
immune responses, but also to the connection between innate and
Th2-type adaptive responses.ATP is another DAMP that is known to drive Th1-type immune
responses, similar to UA. ATP was shown tomediate IL-1b secretion
from macrophages by engaging P2X7 receptors11 and to promote
neutrophil migration thorough P2Y2 receptors.28 Furthermore, ATP
promoted both innate and adaptive Th2-type immune re-
sponses.7,14 For example, ATP regulated the function of DCs and
induced Th2-type cytokine release in bronchial epithelial cells
exposed to aeroallergens. In this study, we found that eosinophils
also responded to ATP and exhibited various functions, including
adhesion, migration, production of pro-inﬂammatory mediators
and degranulation. For example, eosinophils migrated through the
basement membrane matrix towards ATP in a similar manner to
the potent chemotactic factor eotaxin.
We also observed that the inhibition of P2 receptors by a
pharmacologic agent or antibody reduced eosinophil adhesion,
superoxide production and degranulation in response to UA and
ATP. Therefore, ATP itself appears to regulate immune cells involved
in allergic responses. Furthermore, endogenous ATP may be
Fig. 4. Effects of ATPgS on the eosinophil production of superoxide anion by activation
of P2 receptors. (A) Eosinophil and cytochrome C were incubated with or without
various concentrations of ATPgS at 37 C for up to 240 min. O2 generation was
measured as described in Fig. 1 (B) Eosinophils were pre-incubated with oATP (30 mM)
or medium at 4 C for 15 min before assay, and were then incubated with or without
100 mM ATPgS suspension under the same condition. O2 generation at 240 min was
measured as in (A). Results show the mean ± SEM from 6 different eosinophil prep-
arations. *p < 0.05, **p < 0.01, compared with medium alone.
Fig. 5. Effects of ATPgS on eosinophil degranulation by activation of the P2Y2 receptor.
Eosinophils were preincubated with or without rabbit polyclonal anti-P2Y2 Ab or
control IgG (30 mM) at 4 C for 15 min, and were then incubated with 100 mM ATPgS
for 4 h at 37 C and 5% CO2. The EDN ELISAwas performed as described in the Materials
and Methods using ELISA kits. Results show the mean ± SEM from 5 different eosin-
ophil preparations. p < 0.01, compared with medium alone or control IgG.
T. Kobayashi et al. / Allergology International 64 (2015) S30eS36 S35involved in cellular responses to other danger signaling molecules
such as UA. ATP is increased at inﬂammation sites as a result of
various triggers.6,7 Thus, as judged by its potent chemotactic and
stimulatory activities for eosinophils, ATP may play a role in
persistent eosinophil inﬁltration in patients with severe asthma.
Taken together, ATP may serve as pivotal player in allergic inﬂam-
mation in lung.
In this study, ATP induced various functions in human eosino-
phils. These results are consistent with several other studies, which
demonstrate the activities of extracellular nucleotides and ATP
analogues to induce eosinophil functions, including expression of
integrin CD11b, chemotaxis and production of reactive oxygen
metabolites and cytokines.30,34e37 However, little information has
been available on the nature of P2 purinergic receptor(s) involvedbecause of the broad P2 receptor antagonists used. Eosinophils
express mRNA for P2X1, P2X4, P2X7, P2Y1, P2Y2, P2Y4, P2Y11 and
P2Y14.31 We previously veriﬁed the expression of P2Y2 receptors
using ﬂow cytometry.15 We also found that anti-P2Y2 antibody
abrogated cytokine production by eosinophils15 and degranulation
(this study). These observations are consistent with those in in vivo
mouse studies. For example, P2Y2-deﬁcient mice showed reduced
accumulation of eosinophils in the lungs when they were sensi-
tized and challenged with OVA antigen.38 Also, ATP failed to induce
the migration of eosinophils generated from bone marrow of P2Y2-
deﬁcient mice.39 Thus, P2Y2 receptors likely play key roles in the
interaction between eosinophils and ATP.
In summary, human eosinophils exerted diverse functions by
recognizing two danger signals, UA and ATP. ATP was also involved
in UA-induced eosinophil functions, suggesting that ATP potentially
provides a self-sustaining inﬂammation signal to eosinophils, even
when environmental triggers such as viruses and allergens have
been eliminated. Such a mechanism explains the immunologic
mechanism involved in prolonged and sustained airway inﬂam-
mation in patients with difﬁcult-to-treat asthma. Thus, ATP and the
P2Y2 receptor pathway may provide a novel therapeutic target in
future.
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